Aminoglycoside-induced metabolic abnormalities.
Liamis
G
G
Department of Internal Medicine, Medical School, University of Ioannina, Greece.
Alexandridis
G
G
Bairaktari
E T
ET
Elisaf
M S
MS
D000368:Aged; D000617:Aminoglycosides / Q000009:adverse effects* / Q000494:pharmacology*; D002443:Ceftriaxone / Q000009:adverse effects / Q000494:pharmacology; D003404:Creatinine / Q000097:blood / Q000652:urine; D005198:Fanconi Syndrome / Q000139:chemically induced*; D005839:Gentamicins / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008297:Male; D011188:Potassium / Q000097:blood; D014552:Urinary Tract Infections / Q000188:drug therapy
D000617:Aminoglycosides; D005839:Gentamicins; D002443:Ceftriaxone; D003404:Creatinine; D011188:Potassium